Weight loss as a predictor of poor prognosis in patients hospitalized for COVID-19

Author:

Paiva Brena Letícia Gomes deORCID,Barros-Neto João AraújoORCID,Silva Maria Bárbara GaldinoORCID,Silva Clécia Alves daORCID,Augusto Flaviani Diogo ReisORCID,Vasconcelos Sandra Mary LimaORCID,Ramiro Claudia Porto Sabino PinhoORCID

Abstract

Objective: To evaluate the relationship between weight loss and markers of poor prognosis in patients hospitalized with COVID-19 in the state of Pernambuco. Methods: A multicenter, cross-sectional study coupled with prospective analysis variables involving 71 individuals with COVID-19 admitted for hospitalization in 8 public hospitals in Recife, in the State of Pernambuco. Individuals of both sexes, aged ≥ 20 years, hospitalized from June 2020 to June 2021 were included. Sociodemographic, clinical, and nutritional data and prognostic markers were collected. Results: The average age was 54.6±15.6 years, with 54.9% of individuals being male. It was found that 26.8% of the patients were diabetic and 52.1% were hypertensive. The anthropometric profile indicated that 56.3% were overweight and 5.6% were underweight. Positive screening for sarcopenia was observed in 16.9%. The median weight loss was 3.1% (0.0-6.6%), with a loss > 5% evident in 29.6% of the sample. It was found that weight loss was more frequent in men (16 (41.0%) vs. 5 (15.6%); p = 0.020) and that demographic, clinical, and nutritional variables were not associated with body weight loss. There was no statistical association between weight loss and prognostic variables (p NS). Conclusion: Although the study did not demonstrate an association between weight loss and prognostic variables, this should be considered when assessing patients with COVID-19 and should be investigated and treated as an essential health promotion measure.

Publisher

Revista Ciencias em Saude

Subject

General Medicine

Reference34 articles.

1. Sohrabi C, Alsafi Z, Neill NO, Khan M, Kerwan A. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surger. 2020;76:71-6. https://doi.org/10.1016/j.ijsu.2020.02.034

2. Cao T-T, Zhang G-Q, Pellegrini E, Zhao Q, Li J, Luo L, et al. COVID-19 and its effects on the digestive system. World J Gastroenterol. 2021;27(24):3502-15https://doi.org/10.3748/wjg.v27.i24.3502

3. Agência Nacional de Vigilância Sanitária (ANVISA). Nota Técnica No 04/2020 GVIMS /GGTES/ANVISA. Orientações para Serviços de Saúde: Medidas de Prevenção e Controle que Devem Ser Adotadas Durante a Assistência aos Casos Suspeitos ou Confirmados de Infecção pelo novo coronavírus (2019- nCoV). [Internet]. ANVISA: Brasília; 2020. 92 p. Available from: https://bit.ly/3Zkwmce

4. World Health Organization WHO. COVID-19 (Dashboard). [Internet]. Available from: https://covid19.who.int

5. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):taaa021. https://doi.org/10.1093/jtm/taaa021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3